Long‐term secukinumab efficacy and safety in bio‐naïve patients with moderate‐to‐severe cutaneous psoriasis: A real‐world retrospective noninterventional multicentric experience (128 patients)
Abstract Background There is limited evidence over the real‐life secukinumab survival in psoriatic patients, especially in the long‐term bio‐naïve subjects, and to date biological treatments have been assessed in patients with a chronic and recalcitrant psoriasis. It has been hypothesised that early...
Main Authors: | Francisco Javier Melgosa Ramos, Almudena Mateu Puchades, Santiago Guillén Climent, Marta Galarreta Pascual, Marina Saéz Belló, María Angels Martínez Ferrer, Fernando Toledo Alberola, Jorge Magdaleno Tapial, Jose Luís Sánchez Carazo, Javier Matáix Díaz, Luca Schneller‐Pavelescu Apetrei, Laura García Fernández, Iris González Villanueva, Isabel Belinchón Romero, Sergio Martín Jiménez, Sergio Santos Alarcón |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | JEADV Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1002/jvc2.185 |
Similar Items
-
Secukinumab
by: Nilgün Atakan
Published: (2022-04-01) -
Scalp psoriasis: report of efficient treatment with secukinumab
by: Giuseppe Pistone, et al.
Published: (2018-11-01) -
The significance of secukinumab in the treatment of plaque psoriasis
by: Marta Kasprowicz-Furmańczyk, et al.
Published: (2022-02-01) -
Secukinumab in multi-failure psoriatic patients: the last hope?
by: M. Magnano, et al.
Published: (2018-08-01) -
Treatment of psoriatic arthritis with secukinumab: a case series
by: Stefania Nicola, et al.
Published: (2018-11-01)